• SOD2 mRNA-LNP Delivery Mitigates Renal Ischemia-Reperfusion

  2026-05-27

  This study demonstrates that chemically modified SOD2 mRNA, delivered via lipid nanoparticles, significantly reduces oxidative stress and preserves renal function in a mouse model of ischemia-reperfusion injury. The findings highlight a promising mRNA-based therapeutic strategy for acute kidney injury, while also informing translational research in mRNA delivery and reporter assay development.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Research

  2026-05-26

  Salinomycin stands out in hepatocellular carcinoma workflows by targeting both proliferation and apoptosis pathways in cancer cells, with proven in vitro and in vivo efficacy. This article translates benchmark research into actionable protocols, troubleshooting strategies, and comparative applications to help researchers maximize the impact of this polyether ionophore antibiotic in cancer assay development.

• Ceftolozane/Tazobactam: Innovations in Combating Resistant G

  2026-05-26

  The referenced review introduces ceftolozane/tazobactam as a novel cephalosporin/beta-lactamase inhibitor combination with enhanced efficacy against multidrug-resistant gram-negative pathogens, especially Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its unique pharmacodynamics, resistance profile, and clinical evidence represent a significant advance for antibacterial research and the treatment of complicated infections.

• Nigericin Sodium Salt: Practical Guide for Ion Transport Ass

  2026-05-25

  Nigericin sodium salt provides a robust tool for researchers seeking precise modulation of potassium/hydrogen exchange and ion gradients across biological membranes. Its defined solubility, storage, and application parameters make it suitable for studies on cytoplasmic pH regulation, platelet aggregation, and selective lead ion transport. It is not intended for diagnostic, therapeutic, or long-term solution storage applications.

• Catalpol’s Neuroprotective Mechanisms in Alzheimer’s Disease

  2026-05-25

  This paper comprehensively reviews the neuroprotective effects of catalpol, an iridoid glycoside from Rehmannia glutinosa, in Alzheimer’s disease (AD) models. It highlights catalpol’s antioxidant, anti-inflammatory, and antiapoptotic actions, providing mechanistic insights into its multitarget modulation and potential for translational research in neurodegeneration.

• Imatinib Hydrochloride in Cancer Research: Protocols & Insig

  2026-05-24

  Imatinib hydrochloride (STI571 hydrochloride) unlocks precise modulation of oncogenic tyrosine kinases for chronic myelogenous leukemia and GIST research. This guide details optimized experimental workflows, dual-action mechanistic advances, and troubleshooting strategies leveraging APExBIO’s trusted reagent.

• I-BET-762: BET Inhibitor-Driven Ferroptosis & Workflow Maste

  2026-05-23

  I-BET-762 stands out as a high-affinity BET inhibitor, transforming workflows in cancer and inflammation research by effectively synergizing with ferroptosis inducers. This article translates the latest mechanistic discoveries into actionable protocols and troubleshooting strategies for maximizing experimental impact.

• Stiripentol as a Precision LDH Inhibitor: Unraveling Lactate

  2026-05-22

  Explore how Stiripentol, a next-generation LDH inhibitor, enables unprecedented control over lactate-epigenetic coupling in neuroscience research. This article reveals unique practical insights for designing assays that dissect metabolic and immunological crosstalk, setting it apart from existing resources.

• WP1066, JAK2/STAT3 Inhibitor: Translating Pathway Modulation

  2026-05-22

  Discover how WP1066, a potent JAK2/STAT3 inhibitor, uniquely enables researchers to unravel oncogenic and regenerative signaling. This article delves into advanced mechanistic insights, assay optimization, and emerging cross-domain applications.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-05-21

  This study presents a scalable human neuron-based model for investigating herpes simplex virus 1 (HSV-1) latency and reactivation, using sensory neurons differentiated from inducible pluripotent stem cells. The platform bridges key translational gaps, enabling mechanistic and therapeutic studies of HSV-1 latency that were previously limited to animal models.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) in

  2026-05-21

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) is a precision tool for dissecting mitochondrial function and immunometabolic signaling, empowering advanced workflows in cancer and metabolic regulation studies. This article delivers actionable protocols, troubleshooting strategies, and translational insights anchored in the latest research breakthroughs.

• Forskolin (SKU B1421): Reliable cAMP Modulation for Cell Ass

  2026-05-20

  This article provides scenario-driven, evidence-based guidance for using Forskolin (SKU B1421) in cell viability, proliferation, and differentiation assays. Addressing common laboratory challenges, we examine how Forskolin from APExBIO delivers consistent, interpretable results and robust cAMP pathway modulation for biomedical researchers.

• Tropisetron Hydrochloride: Selective 5-HT3 Receptor Antagoni

  2026-05-20

  Tropisetron Hydrochloride is a highly selective 5-HT3 receptor antagonist with dual α7-nicotinic receptor agonist activity. Its IC50 for the 5-HT3 receptor is 70.1 ± 0.9 nM, facilitating precision in serotonin receptor signaling research. The compound is supplied by APExBIO at ≥98% purity, supporting reproducible neuroscience studies.

• Sisomicin Aminoglycoside Antibiotic: Protocols and Troublesh

  2026-05-19

  Sisomicin stands out for its robust inhibition of bacterial protein synthesis, delivering reproducible results in both Gram-negative and Gram-positive infection research. This guide distills evidence-based protocol enhancements, key troubleshooting strategies, and comparative insights to help labs optimize antibacterial workflows with this aminoglycoside antibiotic.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode mRNA Tracking

  2026-05-19

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables real-time visualization and robust quantification of mRNA delivery, providing unmatched clarity for optimizing gene expression workflows. Its dual-modality readout and advanced chemical modifications help researchers minimize immunogenicity and maximize translation efficiency across a spectrum of mammalian cell assays.

455 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page